LNP DELIVERY PLATFORM
Proprietary YolTech-LNPs Demonstrate Multiple Folds Higher in vivo Potency Compared to Industry Benchmark
Our scientists have designed and synthesized thousands of novel ionizable cationic lipids, which have undergone in vivo evaluation for both safety and efficacy.
1.Iterative Approach
2.Solid Screening and Validation Process
3.PD and Scale-Up Consideration
We have established a GMP production platform to support In-house LNP screen and large-scale LNP mRNA drug manufacture.
GMP Capability
-
Target both liver/non-liver organs like spleen, bone marrow 5 times better deliver rate than that of international counterparts
-
Capable of independently producing high-quality LNP-mRNA drugs
-
Strong IP protection with no infringement issues
